Singapore Institute of Advanced Medicine Holdings Ltd. (SGX:9G2)

Market Cap	98.52M
Revenue (ttm)	15.71M
Net Income (ttm)	-27.05M
Shares Out	1.23B
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,898,100
Average Volume	7,923,860
Open	0.0750
Previous Close	0.0720
Day's Range	0.0740 - 0.0890
52-Week Range	0.0260 - 0.0890
Beta	n/a
RSI	73.84
Earnings Date	Oct 29, 2025

About SGXC:9G2

Singapore Institute of Advanced Medicine Holdings Ltd., an investment holding company, provides medical diagnostics and treatments, and radiation therapy and medical oncology services in Singapore. The company offers medical diagnostics and treatments, including cancer-related diagnostics and theragnostic treatments, general diagnostics and health screening, and aesthetic services; and radiation therapy and medical oncology services comprise proton beam therapy, photon radiation therapy, and medical oncology services. It provides clinic and ima...

• Industry: Medical Laboratories
• Founded: 2011
• Country: Singapore
• Stock Exchange: Singapore Exchange - Catalist
• Ticker Symbol: 9G2

Financial Performance

In 2025, SGXC:9G2's revenue was 15.71 million, a decrease of -5.63% compared to the previous year's 16.65 million. Losses were -27.05 million, -27.75% less than in 2024.